Adjuvant treatment in biliary tract cancer: To treat or not to treat?

doi:10.3748/wjg.v18.i21.2591

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4563)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-1) series.

Item

Count

PDF

310

HTML

4123

Tables (1-1)

130

Sum=4563

Jun 7, 2012 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Jun 7, 2012; 18(21): 2591-2596
Published online Jun 7, 2012. doi: 10.3748/wjg.v18.i21.2591

Table 1 Survival outcome for adjuvant chemoradiation

Ref.	No. of patients	Site	Therapy		OS (median)
			Yes	No	CRT	Obs
[38]	73	GB	25	48	58	50
[39]	96	PV	54	42	35.2	16.5
[41]	49	All	34	15	16.4	6.7¹
[42]	48	EHBD	48		44%²	NA
[43]	84	All	34	50	42	29
[44]	125	PV	29	96	67	42
[45]	34	EHBD	34	0	35%²	NA

¹Statistically significant;

²5-year overall survival (OS). CRT: Chemoradiation; Obs: Observation; PV: Papilla of vater; GB: Gallbladder; EHBD: Extrahepatic bile duct; All: PV + GB + EHBD + intrahepatic bile duct; NA: Not applicable.

Citation: Cereda S, Belli C, Reni M. Adjuvant treatment in biliary tract cancer: To treat or not to treat? World J Gastroenterol 2012; 18(21): 2591-2596
URL: https://www.wjgnet.com/1007-9327/full/v18/i21/2591.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i21.2591